Healthcare Stocks

MEDIA-Amgen lays off about 300 workers, citing 'industry headwinds' - Endpoints News

  • January 29, 2023 07:23 PM PST | Reuters
 MEDIA-Amgen lays off about 300 workers, citing 'industry headwinds' - Endpoints News

-- Source link: http://bit.ly/3XOOOIb -- Note: Reuters has not verified this story and does not vouch for its accuracy

Read More...

Varex Imaging Corp expected to post earnings of 20cents a share - Earnings Preview

Varex Imaging Corp expected to post earnings of 20cents a share - Earnings Preview

  • January 27, 2023 04:00 PM PST | Reuters

* Varex Imaging Corp is expected to show a rise in quarterly revenue when it reports results on January 31. * The Salt Lake City Utah-based company is expected to report a 3.3% increase in revenue to

Read More...
Stryker Corp <SYK.N>: Profits of $2.84 per share anticipated for fourth quarter

Stryker Corp <SYK.N>: Profits of $2.84 per share anticipated for fourth quarter

  • January 27, 2023 03:47 PM PST | Reuters

27 January 2023 11:47 p.m. All figures in US dollars. Stryker Corp is expected to show an increase in its fourth quarter earnings to $2.84​ per share according to the mean Refinitiv estimate from

Read More...
Stryker Corp expected to post earnings of $2.84 a share - Earnings Preview

Stryker Corp expected to post earnings of $2.84 a share - Earnings Preview

  • January 27, 2023 03:46 PM PST | Reuters

* Stryker Corp is expected to show a rise in quarterly revenue when it reports results on January 31. * The Kalamazoo Michigan-based company is expected to report a 5.6% increase in revenue to $4.963

Read More...
U.S. FDA Approves Eli Lilly's Drug For Rare Blood Cancer

U.S. FDA Approves Eli Lilly's Drug For Rare Blood Cancer

  • January 27, 2023 03:35 PM PST | Reuters

Jan 27 (Reuters) - * U.S. FDA APPROVES JAYPIRCA™ (PIRTOBRUTINIB), THE FIRST AND ONLY NON-COVALENT (REVERSIBLE) BTK INHIBITOR, FOR ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA AFTER

Read More...
MEDIA-Expert U.S. panel votes for stricter rules on risky virus research - NYT

MEDIA-Expert U.S. panel votes for stricter rules on risky virus research - NYT

  • January 27, 2023 02:56 PM PST | Reuters

-- Source link: https://nyti.ms/3WKkhtJ -- Note: Reuters has not verified this story and does not vouch for its accuracy

Read More...
Inhibikase Therapeutics Announces Closing Of $10 Million Concurrent Registered Direct Offering And Private Placement Priced At A Premium To Market Under Nasdaq Rules

Inhibikase Therapeutics Announces Closing Of $10 Million Concurrent Registered Direct Offering And Private Placement Priced At A Premium To Market Under Nasdaq Rules

  • January 27, 2023 02:48 PM PST | Reuters

Jan 27 (Reuters) - Inhibikase Therapeutics Inc: * INHIBIKASE THERAPEUTICS ANNOUNCES CLOSING OF $10 MILLION CONCURRENT REGISTERED DIRECT OFFERING AND PRIVATE PLACEMENT PRICED AT A PREMIUM TO MARKET

Read More...
Edwards Lifesciences Corp <EW.N>: Profits of 61 cents per share anticipated for fourth quarter

Edwards Lifesciences Corp <EW.N>: Profits of 61 cents per share anticipated for fourth quarter

  • January 27, 2023 02:45 PM PST | Reuters

27 January 2023 10:45 p.m. All figures in US dollars. Edwards Lifesciences Corp is expected to show an increase in its fourth quarter earnings to 61 cents​ per share according to the mean Refinitiv

Read More...
Rvl Pharmaceuticals PLC Files For Mixed Shelf Of Up To $200 Million

Rvl Pharmaceuticals PLC Files For Mixed Shelf Of Up To $200 Million

  • January 27, 2023 02:44 PM PST | Reuters

Jan 27 (Reuters) - RVL Pharmaceuticals PLC: * RVL PHARMACEUTICALS PLC FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING * RVL PHARMACEUTICALS PLC SAYS IN ADDITION, OFFERING OF UP TO 39.4

Read More...
Edwards Lifesciences Corp expected to post earnings of 61cents a share - Earnings Preview

Edwards Lifesciences Corp expected to post earnings of 61cents a share - Earnings Preview

  • January 27, 2023 02:44 PM PST | Reuters

* Edwards Lifesciences Corp is expected to show a rise in quarterly revenue when it reports results on January 31. * The Irvine California-based company is expected to report a 0.1% increase in

Read More...
Assure Holdings Corp Files For Common Stock Offering Size Not Disclosed

Assure Holdings Corp Files For Common Stock Offering Size Not Disclosed

  • January 27, 2023 02:43 PM PST | Reuters

Jan 27 (Reuters) - Assure Holdings Corp: * ASSURE HOLDINGS CORP FILES FOR COMMON STOCK OFFERING; SIZE NOT DISCLOSED - SEC FILING Further company coverage:

Read More...

Frequently Asked Questions

Healthcare stocks are companies involved in the healthcare industry. These companies are engaged in manufacturing. Various pharmaceutical products, including medicine, medical devices, medical care through hospitals and medical centres, health insurance, etc. Despite stock market risks, healthcare stocks can provide substantial returns in the long run. The healthcare sector has been one of the top-performing sectors over the past year. The covid-19 pandemic has accelerated its growth. Some of the top healthcare stocks include Walgreens Boots Alliance Inc. (WBA), Sage Therapeutics Inc. (SAGE), Bio-Rad Laboratories Inc. (BIO), Pfizer Inc, Moderna Inc, etc.

The healthcare sector is one of the largest and most complex sectors in the US, which is comprised of various companies that engage in a wide range of healthcare-related operations. Some of the top healthcare stocks in the US are as follows: UnitedHealth Group Inc. (UNH) Johnson & Johnson (JNJ) Pfizer Inc (PFE) Abbvie Inc (ABBV) Eli Lilly and Co (LLY)

The healthcare sector is one of the centers of attraction of investors in recent days, especially considering the growth potentials of the companies. Some of the best US healthcare stocks are as follows, that maintained has maintained a steady momentum even amid the market downturn. Johnson & Johnson (JNJ) Abbvie Inc (ABBV) Eli Lilly and Co (LLY) Merck & Co Inc (MRK) Bristol-Myers Squibb Co (BMY)

AI healthcare stocks are companies that use artificial intelligence to provide tailor-made products and services to the healthcare industry. The innovation in AI healthcare companies is rapidly transforming the industry. Their help to understand and classify clinical documentation, clinical notes on patients, and insight into methods for better results.